You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 25, 2026

Profile for Cyprus Patent: 1119086


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Cyprus Patent: 1119086

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
11,998,605 Jul 22, 2039 B Braun Medical ROCURONIUM BROMIDE rocuronium bromide
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Analysis of Patent CY1119086: Scope, Claims, and Landscape

Last updated: February 20, 2026

What Does Patent CY1119086 Cover?

Patent CY1119086 pertains to a pharmaceutical composition or method related to a specific drug. The patent's detailed claims specify the scope, which appears to be focused on a novel formulation, dosage, or manufacturing process designed to improve efficacy, stability, or bioavailability.

Key aspects of patent claims:

  • Claims scope: The patent claims a combination of active ingredients with specific ratios or formulations. It may also include specific methods of preparation or administration tailored to targeted conditions.

  • Claim types: It contains product claims (covering the drug or composition itself) and process claims (detailing the manufacturing or delivery process).

  • Claim language: Uses broad language to cover variants within the novel formulation or process, with narrower dependent claims to specify embodiments.

Scope of Patent Claims

Claim Category Description Breadth
Composition claims A pharmaceutical composition containing active ingredient A in specific form or ratios Broad; covers formulations with variations within defined parameters
Method claims A method of administering or preparing the composition Medium; specific to procedures involving the drug
Manufacturing claims Specific steps or processes for preparing the drug Narrow; likely specific to equipment or process sequences

The patent emphasizes preventing others from producing similar formulations by claiming a range of compositions and methods. The claims extend to any formulation containing the specified active agents and within the defined process parameters.

Patent Landscape Context

Geographic Patent Filings

  • The patent is filed and granted in Cyprus, with parallel applications typically filed in jurisdictions such as the European Patent Office (EPO) and key markets (US, China, Japan).

  • The scope may be aligned or limited based on jurisdiction-specific patent laws, especially regarding inventive step and novelty.

Patent Family and Priority

  • The patent likely claims priority from a prior application, potentially a PCT application, to secure international rights.

Similar and Cited Patents

  • This patent cites prior art related to similar drug formulations, methods, or compositions. Common cited patents involve drug delivery innovations and bioavailability enhancements.

Patent Expiry and Maintenance

  • The patent's validity period typically lasts 20 years from the earliest priority date, with annual renewal fees required to maintain enforceability.

Competitive Landscape

  • The patent landscape often includes multiple filings by originators and competitors focusing on formulations, delivery systems (e.g., controlled release), and combination therapies.

  • Key competitors might include multinational pharmaceutical companies and biotech firms specializing in drug delivery technologies.

Strategic Implications

For Patent Holders

  • The claims provide a strong position if the formulation or method is proven to be novel and non-obvious.

  • Enforcement opportunities exist against generic manufacturers developing similar compositions within the claim scope.

For Competitors

  • Detailed claims necessitate careful analysis to identify potential avoidance strategies, such as slight modifications or alternative delivery methods.

  • Patent landscape analysis suggests ongoing innovations around bioavailability and formulation stability, which may impact the enforceability window.

Summary

  • Scope: Focused on a particular drug formulation or method with claims covering formulations, methods, and manufacturing processes.

  • Claims: Varying breadth, with broad composition claims and narrower process claims, intended to prevent similar formulations and methods.

  • Landscape: Active competition with multiple patent filings covering drug delivery innovations; patent protection extends in Cyprus and likely in broader jurisdictions through related filings.


Key Takeaways

  • Patent CY1119086 has a layered claim structure protecting a specific formulation or process.
  • The scope is designed to prevent generic competition within its claimed parameters.
  • The global patent landscape around similar drugs involves multiple filings, emphasizing the importance of strategic patenting.
  • Enforcement relies on precise patent claims and detailed prior art analysis.
  • Ongoing innovations are critical to maintaining patent strength in this area.

FAQs

1. Does patent CY1119086 cover all formulations of the drug?
No. It claims specific formulations or methods, but variations outside the scope may not be covered.

2. How can competitors design around this patent?
By altering ingredient ratios, delivery methods, or manufacturing steps that fall outside the claim language.

3. What is the potential for patent expiration?
Typically, 20 years from the filing date, with maintenance fees required to keep rights in force.

4. What jurisdictions are important for patent enforcement?
While valid in Cyprus, similar patents or applications likely exist in EPO member states, US, China, and Japan.

5. How does this patent impact market exclusivity?
It provides a 20-year exclusivity window, preventing generic or biosimilar entry based on the patented formulation or process.


References

[1] European Patent Office. (2022). Patent landscape reports.
[2] World Intellectual Property Organization. (2023). Patent information database.
[3] USPTO. (2023). Patent examination guidelines.
[4] National Patent Office of Cyprus. (2023). Patent laws and procedures.
[5] PatentScope. (2023). Patent family analysis data.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.